HGHRX
Price
$42.73
Change
-$0.24 (-0.56%)
Updated
Sep 20 closing price
VGHCX
Price
$231.50
Change
-$1.77 (-0.76%)
Updated
Sep 20 closing price
Ad is loading...

HGHRX vs VGHCX

Header iconHGHRX vs VGHCX Comparison
Open Charts HGHRX vs VGHCXBanner chart's image
Hartford Healthcare R3
Price$42.73
Change-$0.24 (-0.56%)
VolumeN/A
CapitalizationN/A
Vanguard Health Care I
Price$231.50
Change-$1.77 (-0.76%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HGHRX vs VGHCX Comparison Chart
Loading...
VS
HGHRX vs. VGHCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a StrongSell and VGHCX is a StrongSell.

FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 51.1B vs. HGHRX (1.14B). VGHCX pays higher dividends than HGHRX: VGHCX (0.79) vs HGHRX (0.00). HGHRX was incepted earlier than VGHCX: HGHRX (18 years) vs VGHCX (40 years). HGHRX is a more actively managed with annual turnover of: 32.00 vs. VGHCX (16.00). HGHRX has a lower initial minimum investment than VGHCX: HGHRX (0) vs VGHCX (3000). HGHRX annual gain was more profitable for investors over the last year : 20.71 vs. VGHCX (11.17). HGHRX return over 5 years is better than : 18.82 vs. VGHCX (17.87).
HGHRXVGHCXHGHRX / VGHCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years40 years-
Gain YTD14.12110.827130%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B51.1B2%
Annual Yield % from dividends0.000.79-
Returns for 1 year20.7111.17185%
Returns for 3 years-8.14-2.45332%
Returns for 5 years18.8217.87105%
Returns for 10 years18.867.81241%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TR32.400.19
+0.59%
Tootsie Roll Industries
HBNC16.090.04
+0.25%
Horizon Bancorp
ATR153.070.04
+0.03%
AptarGroup
SGMT3.38N/A
N/A
Sagimet Biosciences
ONCO0.12-0.01
-6.50%
Onconetix